A Biotech Base
BBK: New Los Angeles Office
The patient recruitment firm discusses the opening of another location.
One way to view the media landscape in 2011 is as a society-wide clinical trial for attention-deficit disorder in which 90 percent of the U.S. population has voluntarily enrolled. Working, walking, driving, shopping, eating, riding bikes, at the movies, attending to bathroom functions—most Americans keep one or both eyes and ears glued to small electronic screens. Such tiny devices offer deliciously addictive electrons of one type or another, and there is no going back to the pre-electronic world. Does all this affect clinical trials? Yes. For some demographic groups, traditional or legacy ad formats are obsolete as some households trim cable TV costs from their tightening budgets. The standard newspaper ad or a radio spot will never reach a broad swath of the public, especially in younger populations and urban locations. But for all the initial appearance of simplicity of sites such as Facebook, Twitter and their kindred dot-com time wasters,…more...
When it comes to finding patients, the clinical site universe is starkly partitioned. Perhaps one clinical site in twenty is superb, reaching difficult patient recruitment goals. Such sites make industry-sponsored research…more...
It was a routine IND meeting at the FDA. Just a few low-level agency staffers were expected to attend. Instead, some of the FDA's most prominent, senior scientific and enforcement leaders…more...
The recruitment of minority patients is hard under any circumstances. But finding research subjects for conditions with a social stigma is especially difficult. Barbara Gladson is director of the biopharma educational…more...
If you're a clinical research site accepting studies from industry, you've probably seen it. The dreaded cross-indemnification clause. It's an increasingly common element of standard contracts. Under cross indemnification, sites take full responsibility if anything goes wrong. That responsibility attaches to the site whether or not a mishap was its fault or the sponsor's. Such clauses have…more...
In the early 1990s, site management organizations (SMOs) began to form. The idea was simple. Sponsors would be happier if they could go to a single company that served as the management headquarters of many sites, instead of having to approach many disparate, individually run sites separately and forge contracts with each. SMOs like Radiant Research started…more...
Within the sprawling Loma Linda Veterans Healthcare System in Redlands, California, sits the non-profit research arm Loma Linda Veterans Association for Research and Education , and in a corner of its 54,000 square foot space in the hospital, there sits the small Clinical Research Group, hard at work on Phase III and IV projects. The 12-person team…more...
In watching respiratory therapists recruit for two studies under way in her departments at both Mount Sinai Hospital and SickKids Hospital in Toronto, neonatologist Sharon Unger thought she saw a trend. It appeared that respiratory therapists were talking to far more parents about entering their infants into the large, multi-center trial that rewarded recruiters for successfully enrolling…more...
The patient recruitment firm discusses the opening of another location.
The best way to keep principal investigators passionate about a commercial research site? Ownership.
A site network discusses how it raised the level of its game.
A nonprofit consortium wants research subjects involved in trials while they are being designed.
Some of the challenges and thinking behind preferred site relationships
An update on how Sanofi-Aventis is managing to stay close to sites.
BBC criticism spurred J&J to look more closely at its informed consent form.
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.